These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 409280)

  • 1. Meningococcal bacteremia: clinical and serologic studies of infants with mild illness.
    Baltimore RS; Hammerschlag M
    Am J Dis Child; 1977 Sep; 131(9):1001-4. PubMed ID: 409280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response of infants and children to disseminated infections with Neisseria meningitidis.
    Griffiss JM; Brandt BL; Broud DD; Goroff DK; Baker CJ
    J Infect Dis; 1984 Jul; 150(1):71-9. PubMed ID: 6431015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of mild systemic meningococcal disease with characterization of bacterial isolates.
    Edwards KM; Jones LM; Stephens DS
    Clin Pediatr (Phila); 1985 Nov; 24(11):617-20. PubMed ID: 3931950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia caused by Neisseria meningitidis.
    Jacobs SA; Norden CW
    JAMA; 1974 Jan; 227(1):67-8. PubMed ID: 4202685
    [No Abstract]   [Full Text] [Related]  

  • 5. Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.
    Martinez J; Pilishvili T; Barnard S; Caba J; Spear W; Romero-Steiner S; Carlone GM
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):485-8. PubMed ID: 11874898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant neonatal meningococcemia.
    Clegg HW; Todres ID; Moylan FM; Keim DE; Shannon DC
    Am J Dis Child; 1980 Apr; 134(4):354-5. PubMed ID: 6768285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.
    Blanchard-Rohner G; Snape MD; Kelly DF; O'Connor D; John T; Kibwana E; Parks H; Ford K; Dull PM; Pollard AJ
    Pediatr Infect Dis J; 2013 Jul; 32(7):768-76. PubMed ID: 23538521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The meningococcal antibody test: how useful in the diagnosis of meningococcal disease?
    Weis N; Berthelsen L; Wachmann H; Lind I
    Epidemiol Infect; 2005 Apr; 133(2):217-27. PubMed ID: 15816146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of group A and group C meningococcal polysaccharides in human infants.
    Goldschneider I; Lepow ML; Gotschlich EC; Mauck FT; Bachl F; Randolph M
    J Infect Dis; 1973 Dec; 128(6):769-76. PubMed ID: 4203078
    [No Abstract]   [Full Text] [Related]  

  • 11. Untreated meningococcemia in two siblings.
    Lindman CR; Frøholm LO; Halstensen AI; Holten E
    NIPH Ann; 1983 Dec; 6(2):191-201. PubMed ID: 6427705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent meningococcal infection with an antigenically identical strain.
    Griffiss JM; Bannatyne RM; Artenstein MS; Anglin CS
    JAMA; 1974 Jul; 229(1):68-70. PubMed ID: 4134964
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
    Klein NP; Habanec T; Kosina P; Shah NR; Kolhe D; Miller JM; Hezareh M; Van der Wielen M
    Vaccine; 2018 Apr; 36(17):2356-2363. PubMed ID: 29576307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of meningococcal infections in the first 2 years of life.
    Woods CR
    Pediatr Ann; 2013 Aug; 42(8):164-71. PubMed ID: 23910030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia associated with meningococcal bacteremia and/or meningitis.
    Llorens-Terol J; Martinez-Roig A; Mur A
    Helv Paediatr Acta; 1984 May; 39(2):187-92. PubMed ID: 6543842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections.
    Black JR; Black WJ; Cannon JG
    J Infect Dis; 1985 Apr; 151(4):650-7. PubMed ID: 3919117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens.
    Galaid EI; Cherubin CE; Marr JS; Schaefler S; Barone J; Lee W
    JAMA; 1980 Nov; 244(19):2167-71. PubMed ID: 6775103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary meningococcal conjuctivitis with the development of a systemic disease].
    Petrousová L; Roznovský L
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):107-8. PubMed ID: 24579454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody response in subjects with meningococal disease and in healthy carriers of Neisseria meningitidis].
    Natoli D; Tringali G; Puma G; Castellini S; Chiarini A
    G Batteriol Virol Immunol; 1976; 69(1-6):64-70. PubMed ID: 828887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.